New research at Wythenshawe Hospital, has the potential to limit the development of antibiotic resistance while improving patient outcomes, when treating very ill patients with pneumonia and sepsis.
A ground-breaking genetic test that could prevent critically ill newborn babies going deaf if treated with a commonly used antibiotic, is being trialled across 14 NHS neonatal units.
New research from the NIHR Manchester Biomedical Research Centre has shown the chance of being correctly diagnosed with asthma varies widely depending on which guidelines are followed.
Nursing, Midwifery and Allied Health Professionals researchers at MFT, are leading UK-first research into youth worker services for young people with long-term conditions.
A woman in Manchester is the first person in the UK to receive an innovative treatment for the most serious form of lupus – an autoimmune condition which can cause damage to the heart, lungs, joints,
Children with a rare type of cancer are part of pioneering research being delivered at Royal Manchester Children's Hospital, that could transform treatment, to improve outcomes and save lives.
Innovative research in Manchester illustrates the potential to dramatically reduce hospitalisations by 58 per cent, improve patient care and save lives.
On Tuesday 10 September 2024, MFT's Innovation Team brought together colleagues from across the NHS, academia and industry to showcase our innovation offer at MFT.